What is the current valuation of the US neurodiagnostics market in 2024?

The overall market valuation was $1800.0 Million in 2024. Read More

What is the projected market size for the US neurodiagnostics market by 2035?

The projected valuation for 2035 is $4000.0 Million. Read More

What is the expected CAGR for the US neurodiagnostics market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 7.53%. Read More

What were the valuations for Diagnostic Imaging Systems in 2024?

The valuation for Diagnostic Imaging Systems ranged from $600.0 Million to $1400.0 Million in 2024. Read More

What was the market valuation for Sleep Disorders in 2024?

The valuation for Sleep Disorders ranged from $540.0 Million to $1200.0 Million in 2024. Read More

Who are the key players in the US neurodiagnostics market?

Key players include Medtronic, Siemens Healthineers, Philips, GE Healthcare, Natus Medical, NeuroWave, Compumedics, and BrainScope. Read More

What are the primary end users of neurodiagnostics products?

Primary end users include Hospitals and Surgical Centers, Diagnostic Laboratories, Neurology Centers, and Ambulatory Care Centers. Read More

What was the market valuation for Hospitals and Surgical Centers in 2024?

The valuation for Hospitals and Surgical Centers ranged from $720.0 Million to $1600.0 Million in 2024. Read More

US Neurodiagnostics Market

Q: Which product types are included in the US neurodiagnostics market?

Key product types include Diagnostic Imaging Systems, Clinical Diagnostic Instruments, and Reagents and Consumables. Read More

Q: What conditions are primarily addressed by the US neurodiagnostics market?

The market addresses conditions such as Neurodegenerative Diseases, Stroke, Epilepsy, Headache Disorders, and Sleep Disorders. Read More

ID: MRFR/MED/17921-HCR

100 Pages

Vikita Thakur

Last Updated: April 06, 2026

US Neurodiagnostics Market Research Report: Size, Share, Trend Analysis By Product Type (Diagnostic Imaging Systems, Clinical Diagnostic Instruments, Reagents and Consumables), By Condition (Neurodegenerative Diseases, Stroke, Epilepsy, Headache Disorders, Sleep Disorders, Others) and By End Users (Hospitals and Surgical Centers, Diagnostic Laboratories and Imaging Centers, Neurology Centers, Ambulatory Care Centers, Research Laboratories and Academic Institutes) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Product Type (USD Million)
  1. 4.1.1 Diagnostic Imaging Systems
  2. 4.1.2 Clinical Diagnostic Instruments
  3. 4.1.3 Reagents and Consumables
2. 4.2 Healthcare, BY Condition (USD Million)
  1. 4.2.1 Neurodegenerative Diseases
  2. 4.2.2 Stroke
  3. 4.2.3 Epilepsy
  4. 4.2.4 Headache Disorders
  5. 4.2.5 Sleep Disorders
  6. 4.2.6 Others
3. 4.3 Healthcare, BY End User (USD Million)
  1. 4.3.1 Hospitals and Surgical Centers
  2. 4.3.2 Diagnostic Laboratories and Imaging Centers
  3. 4.3.3 Neurology Centers
  4. 4.3.4 Ambulatory Care Centers
  5. 4.3.5 Research Laboratories and Academic Institutes
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Siemens Healthineers (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Philips (NL)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 GE Healthcare (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Natus Medical (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 NeuroWave (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Compumedics (AU)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 BrainScope (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY PRODUCT TYPE
3. 6.3 US MARKET ANALYSIS BY CONDITION
4. 6.4 US MARKET ANALYSIS BY END USER
5. 6.5 KEY BUYING CRITERIA OF HEALTHCARE
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF HEALTHCARE
8. 6.8 DRIVERS IMPACT ANALYSIS: HEALTHCARE
9. 6.9 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 SUPPLY / VALUE CHAIN: HEALTHCARE
11. 6.11 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
12. 6.12 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
13. 6.13 HEALTHCARE, BY CONDITION, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY CONDITION, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY END USER, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY CONDITION, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Neurodiagnostics Market Segmentation

US Neurodiagnostics Market By Product Type (USD Million, 2025-2035)

Diagnostic Imaging Systems
Clinical Diagnostic Instruments
Reagents and Consumables

US Neurodiagnostics Market By Condition (USD Million, 2025-2035)

Neurodegenerative Diseases
Stroke
Epilepsy
Headache Disorders
Sleep Disorders
Others

US Neurodiagnostics Market By End User (USD Million, 2025-2035)

Hospitals and Surgical Centers
Diagnostic Laboratories and Imaging Centers
Neurology Centers
Ambulatory Care Centers
Research Laboratories and Academic Institutes

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”